Chemical Compound Review:
S1398_Selleck 1-[5-(hydroxymethyl)-2,5- dihydrofuran-2...
Synonyms:
AG-J-03009, SureCN9999805, ACMC-209hh0, CHEBI:104320, NSC-163661, ...
Antinori,
Trotta,
Nastao,
Bini,
Bonora,
Castagnas,
Zaccarelli,
Quirino,
Landonio,
Merli,
Tozzi,
Di Perri,
Andreoni,
Perno,
Carosi,
Laguno,
Milinkovic,
de Lazzari,
Murillas,
Martínez,
Blanco,
Loncá,
Biglia,
Leon,
García,
Larrousse,
García,
Miró,
Gatell,
Mallolas,
de Ronde,
van Dooren,
van Der Hoek,
Bouwhuis,
de Rooij,
van Gemen,
de Boer,
Goudsmit,
Hulgan,
Haas,
Haines,
Ritchie,
Robbins,
Shafer,
Clifford,
Kallianpur,
Summar,
Canter,
Kallianpur,
Hulgan,
Canter,
Ritchie,
Haines,
Robbins,
Shafer,
Clifford,
Haas,
Wade,
Unadkat,
Huang,
Shapiro,
Mathias,
Yasin,
Ciupak,
Watts,
Delke,
Rathore,
Hitti,
Frenkel,
Samelson,
Smith,
Mofenson,
Burchett,
Calmy,
Pinoges,
Szumilin,
Zachariah,
Ford,
Ferradini,
Walker,
Auclair,
Lebrecht,
Kornprobst,
Capeau,
Caron,
- Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Wainberg, M.A., Drosopoulos, W.C., Salomon, H., Hsu, M., Borkow, G., Parniak, M., Gu, Z., Song, Q., Manne, J., Islam, S., Castriota, G., Prasad, V.R. Science (1996)
- Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients. Antinori, A., Trotta, M.P., Nastao, P., Bini, T., Bonora, S., Castagnas, A., Zaccarelli, M., Quirino, T., Landonio, S., Merli, S., Tozzi, V., Di Perri, G., Andreoni, M., Perno, C.F., Carosi, G. Antivir. Ther. (Lond.) (2006)
- Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions. Walker, U.A., Auclair, M., Lebrecht, D., Kornprobst, M., Capeau, J., Caron, M. Antivir. Ther. (Lond.) (2006)
- Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients. Laguno, M., Milinkovic, A., de Lazzari, E., Murillas, J., Martínez, E., Blanco, J.L., Loncá, M., Biglia, A., Leon, A., García, M., Larrousse, M., García, F., Miró, J.M., Gatell, J.M., Mallolas, J. Antivir. Ther. (Lond.) (2005)
- Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. Hulgan, T., Haas, D.W., Haines, J.L., Ritchie, M.D., Robbins, G.K., Shafer, R.W., Clifford, D.B., Kallianpur, A.R., Summar, M., Canter, J.A. AIDS (2005)
- Microdialysis studies of the distribution of stavudine into the central nervous system in the freely-moving rat. Yang, Z., Brundage, R.C., Barbhaiya, R.H., Sawchuk, R.J. Pharm. Res. (1997)
- Structural basis for activation of alpha-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase. Meyer, P., Schneider, B., Sarfati, S., Deville-Bonne, D., Guerreiro, C., Boretto, J., Janin, J., Véron, M., Canard, B. EMBO J. (2000)
- Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives. Balzarini, J., Karlsson, A., Aquaro, S., Perno, C.F., Cahard, D., Naesens, L., De Clercq, E., McGuigan, C. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Anti-HIV antiviral activity of stavudine in a thymidine kinase-deficient cellular line. Turriziani, O., Simeoni, E., Dianzani, F., Antonelli, G. Antivir. Ther. (Lond.) (1998)
- Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. Johnson, A.A., Ray, A.S., Hanes, J., Suo, Z., Colacino, J.M., Anderson, K.S., Johnson, K.A. J. Biol. Chem. (2001)
- Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. Calmy, A., Pinoges, L., Szumilin, E., Zachariah, R., Ford, N., Ferradini, L. AIDS (2006)
- Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. Martin, A., Smith, D.E., Carr, A., Ringland, C., Amin, J., Emery, S., Hoy, J., Workman, C., Doong, N., Freund, J., Cooper, D.A. AIDS (2004)
- Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting. Maisonneuve, C., Igoudjil, A., Begriche, K., Lettéron, P., Guimont, M.C., Bastin, J., Laigneau, J.P., Pessayre, D., Fromenty, B. Antivir. Ther. (Lond.) (2004)
- The valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance. Selmi, B., Boretto, J., Navarro, J.M., Sire, J., Longhi, S., Guerreiro, C., Mulard, L., Sarfati, S., Canard, B. J. Biol. Chem. (2001)
- Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy. Kallianpur, A.R., Hulgan, T., Canter, J.A., Ritchie, M.D., Haines, J.L., Robbins, G.K., Shafer, R.W., Clifford, D.B., Haas, D.W. AIDS (2006)
- Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. Hoggard, P.G., Kewn, S., Barry, M.G., Khoo, S.H., Back, D.J. Antimicrob. Agents Chemother. (1997)
- Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332. Wade, N.A., Unadkat, J.D., Huang, S., Shapiro, D.E., Mathias, A., Yasin, S., Ciupak, G., Watts, D.H., Delke, I., Rathore, M., Hitti, J., Frenkel, L., Samelson, R., Smith, M.E., Mofenson, L., Burchett, S.K. J. Infect. Dis. (2004)
- Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. Walker, U.A., Setzer, B., Venhoff, N. AIDS (2002)
- 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent. Mansuri, M.M., Starrett, J.E., Ghazzouli, I., Hitchcock, M.J., Sterzycki, R.Z., Brankovan, V., Lin, T.S., August, E.M., Prusoff, W.H., Sommadossi, J.P. J. Med. Chem. (1989)
- Improving patient adherence with antiretroviral therapy: evaluation of once-daily administration of didanosine. Gathe, J.C. AIDS (1998)
- Stavudine plus lamivudine in advanced human immunodeficiency virus disease: a short-term pilot study. Rouleau, D., Conway, B., Raboud, J., Rae, S., Fransen, S., Shillington, A., Zala, C., O'Shaughnessy, M.V., Montaner, J.S. J. Infect. Dis. (1997)
- Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. McGuigan, C., Cahard, D., Sheeka, H.M., De Clercq, E., Balzarini, J. J. Med. Chem. (1996)
- Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patients. Trabattoni, D., Lo Caputo, S., Biasin, M., Seminari, E., Di Pietro, M., Ravasi, G., Mazzotta, F., Maserati, R., Clerici, M. Clin. Diagn. Lab. Immunol. (2002)
- 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. Browne, M.J., Mayer, K.H., Chafee, S.B., Dudley, M.N., Posner, M.R., Steinberg, S.M., Graham, K.K., Geletko, S.M., Zinner, S.H., Denman, S.L. J. Infect. Dis. (1993)
- Monitoring of didanosine and stavudine intracellular trisphosphorylated anabolite concentrations in HIV-infected patients. Becher, F., Landman, R., Mboup, S., Kane, C.N., Canestri, A., Liegeois, F., Vray, M., Prevot, M.H., Leleu, G., Benech, H. AIDS (2004)
- Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both. Ballesteros, A.L., Miró, O., López, S., Fuster, D., Videla, S., Martínez, E., Garrabou, G., Salas, A., Côté, H., Tor, J., Rey-Joly, C., Planas, R., Clotet, B., Tural, C. Antivir. Ther. (Lond.) (2004)
- Mutational Patterns Associated with the 69 Insertion Complex in Multi-drug-resistant HIV-1 Reverse Transcriptase that Confer Increased Excision Activity and High-level Resistance to Zidovudine. Cases-Gonz??lez, C.E., Franco, S., Mart??nez, M.A., Men??ndez-Arias, L. J. Mol. Biol. (2007)
- Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. de Ronde, A., van Dooren, M., van Der Hoek, L., Bouwhuis, D., de Rooij, E., van Gemen, B., de Boer, R., Goudsmit, J. J. Virol. (2001)
- 3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion. August, E.M., Birks, E.M., Prusoff, W.H. Mol. Pharmacol. (1991)